CDH5 and Alzheimer disease: Interestingly, Aβ induces the release of the extracellular domain of VE-cadherin, and, so, elevated plasma levels of soluble VE-cadherin have been detected in AD patients, indicating vascular and BBB damage [72] (Figure 2).